Effect of Nasogastric Tube Care Training by Simulation-Based and Video-Based Methods on Nurses' C… (NCT07541846) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Effect of Nasogastric Tube Care Training by Simulation-Based and Video-Based Methods on Nurses' Confidence, Satisfaction, and Practices
Iraq83 participantsStarted 2026-05-20
Plain-language summary
This randomized controlled trial will evaluate the effect of simulation-based and video-based training on nurses' confidence, satisfaction, and clinical practice related to nasogastric tube care, compared with a control group receiving routine training or usual practice. Nasogastric tube care is an essential nursing procedure that requires adequate knowledge, practical skills, and confidence to ensure safe and effective patient care. Participants will be randomly assigned to one of three groups: simulation-based training, video-based training, or control. The findings of this study will provide evidence on effective educational methods to improve nurses' performance in nasogastric tube care and support better quality of care.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Registered nurses working at the Pediatric Hospital or Kirkuk Teaching
* Hospital in Kirkuk
* Male or female nurses
* Age 18 years or older
* Nurses involved in direct patient care
* Nurses willing to participate in the study
* Nurses able to attend the assigned training and complete the study assessments
Exclusion Criteria:
* Nurses who do not agree to participate in the study
* Nurses who are not available during the study period
* Nurses who are unable to attend the assigned training session
* Nurses who do not complete the required study assessments
* Nurses who participated in the pilot study
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Nurses' clinical practice in nasogastric tube care
Timeframe: Immediately after completion of the assigned training intervention (post-test 1) and 4 weeks after completion of the intervention (post-test 2).